Table D91: Brachytherapy — Ear, Nose, Mouth and Throat
Row 1
- Treatment Site:
0 Ear; 1 Nose; 3 Hypopharynx; 4 Mouth; 5 Tongue; 6 Salivary Glands; 7 Sinuses; 8 Hard Palate; 9 Soft Palate; B Larynx; D Nasopharynx; F Oropharynx - Modality Qualifier:
9 High Dose Rate (HDR) - Isotope:
7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); B Palladium 103 (Pd-103); C Californium 252 (Cf-252); Y Other Isotope - Qualifier:
Z None
Row 2
- Treatment Site:
0 Ear; 1 Nose; 3 Hypopharynx; 4 Mouth; 5 Tongue; 6 Salivary Glands; 7 Sinuses; 8 Hard Palate; 9 Soft Palate; B Larynx; D Nasopharynx; F Oropharynx - Modality Qualifier:
B Low Dose Rate (LDR) - Isotope:
6 Cesium 131 (Cs-131); 7 Cesium 137 (Cs-137); 8 Iridium 192 (Ir-192); 9 Iodine 125 (I-125); C Californium 252 (Cf-252); Y Other Isotope - Qualifier:
Z None
Row 3
- Treatment Site:
0 Ear; 1 Nose; 3 Hypopharynx; 4 Mouth; 5 Tongue; 6 Salivary Glands; 7 Sinuses; 8 Hard Palate; 9 Soft Palate; B Larynx; D Nasopharynx; F Oropharynx - Modality Qualifier:
B Low Dose Rate (LDR) - Isotope:
B Palladium 103 (Pd-103) - Qualifier:
1 Unidirectional Source; Z None